Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis
Wei Qiu(Sun Yat-sen University), Xianhao Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Meini Zhang(Shanxi Medical University), Dehui Huang(Chinese People's Liberation Army), Gang Zhao(Shanghai Jiao Tong University), Tao Jin(Jilin University), Xinghu Zhang(National Clinical Research Center for Digestive Diseases), Chaodong Zhang(East China Jiaotong University), Dong Zhou(Sichuan University), Baojun Wang(Capital Medical University), Bitao Bu(Tongji Hospital), Huiqing Dong(Capital Medical University), Haifeng Li(University of Macau), Ling Li(First Affiliated Hospital of Zhengzhou University), Xu Zhang(Huizhou Central People's Hospital), Yan Cheng(Second Affiliated Hospital of Xi'an Jiaotong University), Weiping Wu(Chinese People's Liberation Army), Hua Peng(Second Military Medical University), Xueqiang Hu(Guangdong University of Technology), Yining Huang(Nanjing University of Chinese Medicine), Jimei Li(Jimei University), Shifang Hou(Beijing Hospital), Chuanzhen Lü(Fudan University), Dongsheng Fan(King University)
Cited by 15
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554